| | COMPOUND: C07037 | |
Entry |
|
Name |
|
Formula |
C9H9Cl2N3O
|
Exact mass |
245.0123
|
Mol weight |
246.0933
|
Structure |
|
Remark |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
C02AC Imidazoline receptor agonists
C02AC02 Guanfacine
D08031 Guanfacine (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01738 Centrally-acting antiadrenergic
DG00250 Guanfacine
D08031 Guanfacine
DG01456 Adrenergic receptor agonist
DG01450 alpha-Adrenergic receptor agonist
DG01449 alpha2-Adrenergic receptor agonist
DG00250 Guanfacine
D08031 Guanfacine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00250 Guanfacine
D08031 Guanfacine
DG02925 CYP3A5 substrate
DG00250 Guanfacine
D08031 Guanfacine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA2A
D08031 Guanfacine (INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08031
|
Other DBs |
|
KCF data |
ATOM 15
1 C8y C 25.4371 -16.1296
2 C1b C 24.2200 -15.4251
3 C8y C 25.4254 -17.5215
4 C8y C 26.6425 -15.4194
5 C5a C 23.0146 -16.1296
6 C8x C 26.6425 -18.2203
7 X Cl 24.2143 -18.2144
8 C8x C 27.8537 -16.1180
9 X Cl 26.6366 -14.0158
10 N1b N 21.8034 -15.4251
11 O5a O 23.0146 -17.5273
12 C8x C 27.8537 -17.5215
13 C2c C 20.5863 -16.1296
14 N1a N 19.3750 -15.4251
15 N2a N 20.5863 -17.5273
BOND 15
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 1
7 4 8 2
8 4 9 1
9 5 10 1
10 5 11 2
11 6 12 2
12 10 13 1
13 13 14 1
14 13 15 2
15 8 12 1
|
|
» Japanese version
|
|